2025
SJR Q3
JCR Q4 · 1,8
69 matched articles
SCIE
Journal detail
American Journal of Clinical Oncology: Cancer Clinical Trials
- Publisher
- Lippincott Williams and Wilkins
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
027737321537453X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,647
- Quartile Q3
- H-Index 95
- Cites/doc 1,73
- Docs (3y) 257
- Cites (3y) 452
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,8
- 5Y JIF 1,9
- JCI 0,36
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q3
- Oncology Q3
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,647 | 1,8 | 1,9 | 0,36 | Q4 | 95 |
| 2024 | Q3 | Q4 | 0,696 | 1,8 | 1,9 | 0,39 | Q3 | 93 |
| 2023 | Q2 | Q4 | 0,711 | 1,7 | 2,1 | 0,46 | Q3 | 93 |
| 2022 | Q2 | Q3 | 0,916 | 2,6 | 2,6 | 0,47 | Q3 | 93 |
| 2021 | Q2 | Q4 | 0,795 | 2,8 | 3,1 | 0,5 | Q3 | 93 |
| 2020 | Q2 | Q4 | 0,896 | 2,3 | 2,8 | 0,5 | Q3 | 93 |
| 2019 | Q2 | Q4 | 1,06 | 1,9 | 2,3 | 0,64 | Q3 | 93 |
| 2018 | — | Q3 | — | 3 | 2,6 | 0,69 | Q2 | — |
| 2017 | Q2 | Q2 | 0,973 | 3,4 | 2,7 | 0,6 | Q3 | 93 |
| 2016 | Q2 | Q2 | 0,901 | 3,3 | 2,8 | — | — | 93 |
| 2015 | Q2 | Q2 | 0,936 | 3 | 2,4 | — | — | 93 |
| 2014 | Q2 | Q2 | 1,031 | 3,1 | 2,3 | — | — | 93 |
| 2013 | Q2 | Q3 | 1,005 | 2,6 | 2,3 | — | — | 93 |
| 2012 | Q2 | Q3 | 0,935 | 2,6 | 2,2 | — | — | 93 |
| 2011 | Q2 | Q3 | 0,9 | 2 | 1,9 | — | — | 93 |
| 2010 | Q2 | Q3 | 0,944 | 1,8 | 1,9 | — | — | 93 |
| 2009 | — | Q3 | — | 2,2 | 1,8 | — | — | — |
| 2008 | — | Q4 | — | 1,8 | 1,9 | — | — | — |
| 2007 | — | Q4 | — | 1,6 | 1,7 | — | — | — |
| 2006 | — | Q4 | — | 1,2 | — | — | — | — |
| 2005 | — | Q3 | — | 1,6 | — | — | — | — |
| 2004 | — | Q3 | — | 1,7 | — | — | — | — |
| 2003 | — | Q3 | — | 1,4 | — | — | — | — |
| 2002 | — | Q4 | — | 1,1 | — | — | — | — |
| 2001 | — | Q4 | — | 0,9 | — | — | — | — |
| 2000 | — | Q4 | — | 1 | — | — | — | — |
| 1999 | — | Q3 | — | 1 | — | — | — | — |
| 1998 | — | Q3 | — | 0,9 | — | — | — | — |
| 1997 | — | Q3 | — | 0,8 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q4 | Q4 | 264/333 |
| 2024 | ONCOLOGY | SCIE | Q4 | Q3 | 253/328 |
| 2023 | ONCOLOGY | SCIE | Q4 | Q3 | 250/322 |
| 2022 | ONCOLOGY | SCIE | Q3 | Q3 | 176/241 |
| 2021 | ONCOLOGY | SCIE | Q4 | Q3 | 194/245 |
| 2020 | ONCOLOGY | SCIE | Q4 | Q3 | 216/242 |
| 2019 | ONCOLOGY | SCIE | Q4 | Q3 | 210/244 |
| 2018 | ONCOLOGY | SCIE | Q3 | Q2 | 116/230 |
| 2017 | ONCOLOGY | SCIE | Q2 | Q3 | 98/223 |
| 2016 | ONCOLOGY | SCIE | Q2 | — | 96/217 |
| 2015 | ONCOLOGY | SCIE | Q2 | — | 101/213 |
| 2014 | ONCOLOGY | SCIE | Q2 | — | 93/211 |
| 2013 | ONCOLOGY | SCIE | Q3 | — | 108/203 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 101/197 |
| 2011 | ONCOLOGY | SCIE | Q3 | — | 123/196 |
| 2010 | ONCOLOGY | SCIE | Q3 | — | 133/185 |
| 2009 | ONCOLOGY | SCIE | Q3 | — | 91/166 |
| 2008 | ONCOLOGY | SCIE | Q4 | — | 110/143 |
| 2007 | ONCOLOGY | SCIE | Q4 | — | 100/132 |
| 2006 | ONCOLOGY | SCIE | Q4 | — | 113/127 |
| 2005 | ONCOLOGY | SCIE | Q3 | — | 89/123 |
| 2004 | ONCOLOGY | SCIE | Q3 | — | 84/123 |
| 2003 | ONCOLOGY | SCIE | Q3 | — | 89/120 |
| 2002 | ONCOLOGY | SCIE | Q4 | — | 90/114 |
| 2001 | ONCOLOGY | SCIE | Q4 | — | 86/107 |
| 2000 | ONCOLOGY | SCIE | Q4 | — | 80/103 |
| 1999 | ONCOLOGY | SCIE | Q3 | — | 73/105 |
| 1998 | ONCOLOGY | SCIE | Q3 | — | 71/104 |
| 1997 | ONCOLOGY | SCIE | Q3 | — | 69/102 |